Health Care FundRYHCX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$19.2M
Expense ratio
—
1-year return
+5.6%
3 years, a year
+4.2%
5 years, a year
+2.7%
Holdings
136
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co. | 3.67% |
| JNJ Johnson & Johnson | 3.25% |
| ABBV AbbVie Inc. | 2.57% |
| MRK Merck & Co., Inc | 2.34% |
| UNH UnitedHealth Group Inc. | 2.09% |
| TMO Thermo Fisher Scientific Inc | 1.87% |
| AMGN Amgen Inc. | 1.82% |
| ABT Abbott Laboratories | 1.74% |
| PFE Pfizer Inc. | 1.74% |
| GILD Gilead Sciences Inc. | 1.72% |
More on RYHCX.
- RYHCX overview
- RYHCX holdings
- RYHCX risk
- RYHCX costs
- RYHCX money in and out
- RYHCX share classes
- Compare RYHCX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.